Brown and Company PLC (COSE:BRWN.N0000)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions LKR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	39,601	33,648	23,389	25,409	28,385	33,010
Market Cap Growth	43.86%	43.86%	-7.95%	-10.49%	-14.01%	269.64%
Enterprise Value	345,497	286,698	235,622	234,065	139,429	133,453
Last Close Price	186.25	158.25	110.00	119.50	133.50	155.25
PE Ratio	1.03	1.04	9.82	-	1.32	-
PS Ratio	0.37	0.31	0.29	0.35	0.56	1.12
PB Ratio	0.14	0.12	0.12	0.15	0.16	0.34
P/TBV Ratio	0.40	0.34	0.34	0.33	0.34	0.73
P/FCF Ratio	-	-	-	9.55	1.23	-
P/OCF Ratio	-	-	1.94	1.51	1.00	-
EV/Sales Ratio	3.20	2.66	2.92	3.22	2.77	4.54
EV/EBITDA Ratio	20.85	18.70	41.46	16.36	32.05	43.99
EV/EBIT Ratio	52.21	53.27	221.26	27.39	63.25	237.51
EV/FCF Ratio	-8.44	-	-	87.96	6.05	-
Debt / Equity Ratio	0.55	0.55	0.56	0.62	0.59	0.61
Debt / EBITDA Ratio	9.90	9.90	15.75	6.81	21.80	17.60
Debt / FCF Ratio	-	-	-	40.27	4.72	-
Asset Turnover	0.16	0.16	0.16	0.17	0.17	0.17
Inventory Turnover	2.98	2.98	2.66	2.36	2.64	2.82
Quick Ratio	0.21	0.21	0.23	0.27	0.31	0.30
Current Ratio	0.40	0.40	0.33	0.39	0.47	0.46
Return on Equity (ROE)	12.54%	12.54%	-4.72%	-7.04%	21.22%	-3.85%
Return on Assets (ROA)	0.51%	0.51%	0.13%	1.21%	0.45%	0.21%
Return on Capital (ROIC)	0.93%	0.93%	0.23%	1.87%	0.61%	0.26%
Return on Capital Employed (ROCE)	1.40%	1.40%	0.40%	3.50%	0.90%	0.40%
Earnings Yield	81.87%	96.36%	10.18%	-24.52%	76.06%	-0.05%
FCF Yield	-103.42%	-121.72%	-1.38%	10.47%	81.16%	-19.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.